ANI PHARMACEUTICALS INC 10-Q filing
Filed 2025-08-08 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001023024-25-000082
- Form type
- 10-Q
- CIK
- 0001023024
- Primary document
- https://www.sec.gov/Archives/edgar/data/1023024/000102302425000082/anip-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ANI PHARMACEUTICALS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $408.5M | - | - |
| Operating Income | $40.1M | - | - |
| Net Income | $24.2M | - | - |
| Eps Basic | 1.07 | - | - |
| Eps Diluted | 1.05 | - | - |
| Cash And Equivalents | $217.8M | - | - |
| Total Assets | $1.3B | - | - |
| Total Liabilities | $881.4M | - | - |
| Shareholders Equity | $436.8M | - | - |
| Operating Cash Flow | $110.8M | - | - |
| Capital Expenditures | $6.5M | - | - |